CTRL Therapeutics

cTRL Therapeutics is developing a proprietary technology that can extract circulating tumor-reactive lymphocytes (cTRLs) from blood to fulfill unmet needs associated with cell therapy.

Year Established: 2022 Stock Ticker: Exchange:

Locations

  • CTRL Therapeutics

     San Francisco CA

    cTRL Therapeutics is developing a proprietary technology that can extract circulating tumor-reactive lymphocytes (cTRLs) from blood to fulfill unmet needs associated with cell therapy.

  • CTRL Therapeutics

     Chicago IL

    cTRL Therapeutics is developing a proprietary technology that can extract circulating tumor-reactive lymphocytes (cTRLs) from blood to fulfill unmet needs associated with cell therapy.